SIGA Declares Special Dividend of $0.45 Per Share
05 mai 2022 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special...
SIGA Technologies to Host Business Update Call on May 5th, 2022 Following Release of First Quarter 2022 Financial Results
28 avr. 2022 16h05 HE
|
SIGA Technologies Inc.
NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2021
03 mars 2022 16h05 HE
|
SIGA Technologies Inc.
- Approximately $113 Million of U.S. Product Sales in 2021 – - Approximately $13 Million of International Product Sales in 2021 – - Corporate Update Conference Call Today at 4:30...
SIGA Announces Start of TPOXX® Post-Exposure Prophylactic (“PEP”) Clinical Trials
02 mars 2022 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Technologies to Host Business Update Call on March 3rd, 2022 Following Release of Fourth Quarter and Full Year 2021 Financial Results
24 févr. 2022 10h27 HE
|
SIGA Technologies Inc.
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Announces Preclinical Oncology Research Collaboration with Bioarchitech
25 janv. 2022 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Jan. 25, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Technologies to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022
18 janv. 2022 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, announced today that it...
SIGA Technologies Receives Approval from the European Medicines Agency for Tecovirimat
10 janv. 2022 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Jan. 10, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the...
SIGA Announces Health Canada Regulatory Approval of Oral TPOXX®
01 déc. 2021 09h55 HE
|
SIGA Technologies Inc.
NEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval of Tecovirimat
16 nov. 2021 08h30 HE
|
SIGA Technologies Inc.
- Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications - NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a...